Suppr超能文献

与注意力缺陷多动障碍共病的精神障碍:一个重要的知识空白。

Psychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gap.

作者信息

Levy Emmanuelle, Traicu Alexandru, Iyer Srividya, Malla Ashok, Joober Ridha

机构信息

Assistant Professor, Department of Psychiatry, McGill University, Montreal, Quebec; Psychiatrist, Douglas Mental Health University Institute, Montreal, Quebec.

Psychiatrist, Douglas Mental Health University Institute, Montreal, Quebec.

出版信息

Can J Psychiatry. 2015 Mar;60(3 Suppl 2):S48-52.

Abstract

Psychotic disorders (PDs) and attention-deficit hyperactivity disorder (ADHD) are frequently comorbid. Clinicians are often reticent to treat ADHD in patients with psychosis, fearing that psychostimulants will worsen psychotic symptoms. Advances in neurobiology have challenged the simplistic dichotomy where PD is considered a disorder of high dopamine (DA), treated by DA antagonists, and ADHD a disorder of low DA, treated by DA agonists. In our paper, we review the literature on comorbid ADHD and psychosis. Treating ADHD with psychostimulants may be considered in patients with PD who have been stabilized with antipsychotics (APs). Not treating ADHD may have consequences because ADHD may predispose patients to drug abuse, which further increases the risk of PD. Nevertheless, more systematic studies are needed as there remains some uncertainty on the combined use of APs and psychostimulants in comorbid PD and ADHD.

摘要

精神障碍(PDs)和注意力缺陷多动障碍(ADHD)常常共病。临床医生通常不愿治疗患有精神病的ADHD患者,担心精神兴奋剂会加重精神病症状。神经生物学的进展对这种简单的二分法提出了挑战,即PD被认为是一种高多巴胺(DA)紊乱,用DA拮抗剂治疗,而ADHD是一种低DA紊乱,用DA激动剂治疗。在我们的论文中,我们回顾了关于共病ADHD和精神病的文献。对于已用抗精神病药物(APs)稳定病情的PD患者,可以考虑用精神兴奋剂治疗ADHD。不治疗ADHD可能会产生后果,因为ADHD可能使患者易患药物滥用,这进一步增加了患PD的风险。然而,由于在共病PD和ADHD中联合使用APs和精神兴奋剂仍存在一些不确定性,因此需要进行更系统的研究。

相似文献

4
Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy.
Pharmacopsychiatry. 2016 Mar;49(2):45-50. doi: 10.1055/s-0035-1565132. Epub 2016 Feb 1.
5
First episode psychosis and comorbid ADHD, autism and intellectual disability.
Eur Psychiatry. 2019 Jan;55:18-22. doi: 10.1016/j.eurpsy.2018.09.007. Epub 2018 Oct 29.
7
Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.
Eur J Paediatr Neurol. 2013 Sep;17(5):421-8. doi: 10.1016/j.ejpn.2013.01.005. Epub 2013 Mar 7.
10
Stimulant drug treatment in childhood-onset schizophrenia with comorbid ADHD: an open-label case series.
J Child Adolesc Psychopharmacol. 2004 Fall;14(3):448-54. doi: 10.1089/cap.2004.14.448.

引用本文的文献

1
Long term safety of ADHD medication in patients with schizophrenia spectrum disorders.
Mol Psychiatry. 2025 Jul 1. doi: 10.1038/s41380-025-03080-3.
2
Comorbid ADHD and schizophrenia and the use of psychostimulants: a scoping review protocol.
BMJ Open. 2024 Oct 23;14(10):e090290. doi: 10.1136/bmjopen-2024-090290.
6
Psychosis Induced by Methylphenidate in Children and Young Patients With Attention-Deficit Hyperactivity Disorder.
Cureus. 2023 Jan 28;15(1):e34299. doi: 10.7759/cureus.34299. eCollection 2023 Jan.
7
Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea.
Clin Psychopharmacol Neurosci. 2022 Feb 28;20(1):126-134. doi: 10.9758/cpn.2022.20.1.126.
8
Attention-deficit/hyperactivity disorder in youth with psychosis spectrum symptoms.
Schizophr Res. 2021 Nov;237:141-147. doi: 10.1016/j.schres.2021.08.027. Epub 2021 Sep 13.
10
Characteristics of child psychiatric outpatients with slow processing speed and potential mechanisms of academic impact.
Eur Child Adolesc Psychiatry. 2020 Oct;29(10):1453-1464. doi: 10.1007/s00787-019-01455-w. Epub 2020 Jan 24.

本文引用的文献

1
Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011.
J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):34-46.e2. doi: 10.1016/j.jaac.2013.09.001. Epub 2013 Nov 21.
2
Stimulant medication and substance use outcomes: a meta-analysis.
JAMA Psychiatry. 2013 Jul;70(7):740-9. doi: 10.1001/jamapsychiatry.2013.1273.
3
Risk of bipolar disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder.
Br J Psychiatry. 2013 Aug;203(2):103-6. doi: 10.1192/bjp.bp.112.120808. Epub 2013 May 23.
4
A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: challenges and therapeutic opportunities.
Schizophr Res. 2013 Jul;147(2-3):241-52. doi: 10.1016/j.schres.2013.03.019. Epub 2013 Apr 22.
5
Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis.
J Clin Psychiatry. 2012 Apr;73(4):468-75. doi: 10.4088/JCP.11r07222.
7
Childhood symptoms of inattention-hyperactivity predict cannabis use in first episode psychosis.
Schizophr Res. 2011 Nov;132(2-3):171-6. doi: 10.1016/j.schres.2011.06.027. Epub 2011 Jul 20.
8
Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis.
Schizophr Res. 2011 Mar;126(1-3):81-6. doi: 10.1016/j.schres.2010.11.025. Epub 2010 Dec 24.
9
Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate.
Curr Neuropharmacol. 2008 Dec;6(4):322-8. doi: 10.2174/157015908787386069.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验